Skip to main content

Advertisement

SpringerLink
Log in

Gynaecological Oncology in India: Past, Present and Future

  • Review Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Gynaecological cancers contribute to a substantial portion of the global cancer burden. Traditionally, these cancers have been treated by generalists, including gynaecologists and surgeons. However, owing to increasing sophistication and challenges in their management, a new sub-speciality of Gynaecologic Oncology, dedicated to these women’s comprehensive care, has emerged in recent times. The emergence and evolution of this sub-speciality will facilitate a holistic approach to treating women suffering from gynaecological cancers, including tailored surgical techniques, fertility preservation, precision medicine, hormone modulators, targeted therapy and immunotherapy, which can be achieved within the framework of multidisciplinary management. Hence, we decided to write this synopsis to shed light on the evolution of this discipline in India and offer current and future perspectives.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organisation(WHO) The Global Cancer Observatory(GLOBOCAN). https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-sheets.pdf. Accessed 7 Aug 2022

  2. du Bois A, Rochon J, Pfisterer J, Hoskins WJ (2009) Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review. Gynecol Oncol 112(2):422–36. https://doi.org/10.1016/j.ygyno.2008.09.036

    Article  Google Scholar 

  3. Vernooij F, Heintz P, Witteveen E, van der Graaf Y (2007) The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. Gynecol Oncol 105(3):801–12. https://doi.org/10.1016/j.ygyno.2007.02.030

    Article  Google Scholar 

  4. Fung-Kee-Fung M, Kennedy EB, Biagi J et al (2015) The optimal organization of gynecologic oncology services: a systematic review. Curr Oncol 22(4):e282-93. https://doi.org/10.3747/co.22.2482

    Article  CAS  Google Scholar 

  5. Franasiak JM, Scott RT (2016) Demographics of cancer in the reproductive age female. In: Sabanegh, Jr E (ed) Cancer and fertility. Current clinical urology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-27711-0_2

    Chapter  Google Scholar 

  6. Averette HE, Wrennick A, Angioli R (2001) History of gynecologic oncology subspecialty. Surg Clin North Am 81(4):747–51. https://doi.org/10.1016/S0039-6109(05)70162-6

    Article  CAS  Google Scholar 

  7. Banerjee S, Mahantshetty U, Shrivastava S (2014) Brachytherapy in India — a long road ahead. J Contemp Brachytherapy 6(3):331–5. https://doi.org/10.5114/jcb.2014.45761

    Article  Google Scholar 

  8. Shrivastava S (2005) Brachytherapy — perspectives in evolution: take it with a bag of salt. J Cancer Res Ther 1(2):73–4. https://doi.org/10.4103/0973-1482.16704

    Article  Google Scholar 

  9. Munshi A, Ganesh T, Mohanti B (2019) Radiotherapy in India: history, current scenario and proposed solutions. Indian J Cancer 56(4):359–363. https://doi.org/10.4103/ijc.IJC_82_19

    Article  Google Scholar 

  10. Sushruta, Bhishagratha KL (1963) An English Translation of the Sushrutha Samhita: Based on Original Sanskrit Text, 2nd edn. Chowkhamba Sanskrit, Varanasi

    Google Scholar 

  11. Charaka, Kaviratna AC (1991) Charaka Samhita: Translated into English. Choukambha Sanskrit, Varanasi

    Google Scholar 

  12. Mitra S (1959) Extraperitoneal lymphadenectomy and radical vaginal hysterectomy for cancer of the cervix (Mitra technique). Am J Obstet Gynecol 78(1):191–6. https://doi.org/10.1016/0002-9378(59)90661-1

    Article  CAS  Google Scholar 

  13. Dixit V (2018) Unknown facets of “Not so well-known scientist” Dr. Y Subbarow: a great scientist, who did not receive the Nobel Prize. J Mar Med Soc 20(2):141. https://doi.org/10.4103/jmms.jmms_69_18

    Article  Google Scholar 

  14. Maheshwari A, Kumar N, Mahantshetty U (2016) Gynecological cancers: a summary of published Indian data. South Asian J Cancer 05(03):112–20. https://doi.org/10.4103/2278-330X.187575

    Article  Google Scholar 

  15. Shastri SS, Mittra I, Mishra GA et al (2014) Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. JNCI J Natl Cancer Ins 106(3):dju009. https://doi.org/10.1093/jnci/dju009

    Article  Google Scholar 

  16. Sankaranarayanan R, Esmy PO, Rajkumar R et al (2007) Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 370(9585):398–406. https://doi.org/10.1016/S0140-6736(07)61195-7

    Article  Google Scholar 

  17. Sankaranarayanan R, Nene BM, Shastri SS et al (2009) HPV screening for cervical cancer in rural India. N Engl J Med 360(14):1385–94. https://doi.org/10.1056/NEJMoa0808516

    Article  CAS  Google Scholar 

  18. Sankaranarayanan R, Joshi S, Muwonge R et al (2018) Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study. Vaccine 36(32):4783–4791. https://doi.org/10.1016/j.vaccine.2018.02.087

    Article  Google Scholar 

  19. Singh M, Jha RP, Shri N, Bhattacharyya K, Patel P, Dhamnetiya D (2022) Secular trends in incidence and mortality of cervical cancer in India and its states, 1990–2019: data from the Global Burden of Disease 2019 Study. BMC Cancer 22(1):149. https://doi.org/10.1186/s12885-022-09232-w

    Article  Google Scholar 

  20. Gupta S, Kerkar RA, Dikshit R, Badwe RA (2013) Is human papillomavirus vaccination likely to be a useful strategy in India? South Asian J Cancer 02(04):193–7. https://doi.org/10.4103/2278-330X.119887

    Article  Google Scholar 

  21. Shrivastava S, Mahantshetty U, Engineer R et al (2018) Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix. JAMA Oncol 4(4):506–513. https://doi.org/10.1001/jamaoncol.2017.5179

    Article  Google Scholar 

  22. Gupta S, Maheshwari A, Parab P et al (2018) Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a randomized controlled trial. J Clin Oncol 36(16):1548–1555. https://doi.org/10.1200/JCO.2017.75.9985

    Article  CAS  Google Scholar 

  23. Chopra S, Gupta S, Kannan S et al (2021) Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial. J Clin Oncol 39(33):3682–3692. https://doi.org/10.1200/JCO.20.02530

    Article  CAS  Google Scholar 

  24. Mahantshetty U, Teni T, Naga P et al (2018) Impact of HPV 16/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy — a prospective observational study. Gynecol Oncol 148(2):299–304. https://doi.org/10.1016/j.ygyno.2017.11.034

    Article  Google Scholar 

  25. Bhatla N, Berek JS, Cuello Fredes M et al (2019) Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynecol Obstet 145(1):129–135. https://doi.org/10.1002/ijgo.12749

    Article  Google Scholar 

  26. Bhatla N, Singhal S, Dhamija E, Mathur S, Natarajan J, Maheshwari A (2021) Implications of the revised cervical cancer FIGO staging system. Indian J Med Res 154(2):273–283. https://doi.org/10.4103/ijmr.IJMR_4225_20

    Article  CAS  Google Scholar 

  27. Kumar A, Chopra S, Gupta S (2021) Contribution of Tata Memorial Centre, India, to cervical cancer care: journey of two decades. Indian J Med Res 154(2):319–328. https://doi.org/10.4103/ijmr.IJMR_339_21

    Article  CAS  Google Scholar 

  28. Chopra SJ, Mathew A, Maheshwari A et al (2018) National cancer grid of India consensus guidelines on the management of cervical cancer. J Glob Oncol 4:1–15. https://doi.org/10.1200/JGO.17.00152

    Article  Google Scholar 

  29. Maheshwari A, Kumar N, Gupta S et al (2018) Outcomes of advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy. Indian J Cancer 55(1):50–54. https://doi.org/10.4103/ijc.IJC_468_17

    Article  Google Scholar 

  30. Gupta S, Rajappa S, Advani S, Agarwal A, Aggarwal S, Goswami C, Palanki SD, Arya D, Patil S, Kodagali R (2021) Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study. JCO Glob Oncol. 7:849–861. https://doi.org/10.1200/GO.21.00051. PMID: 34101484; PMCID: PMC8457852

  31. Agarwal A, Baghmar S, Dodagoudar C et al (2021) PARP inhibitor in platinum-resistant ovarian cancer: single-center real-world experience. JCO Glob Oncol 7:506–511. https://doi.org/10.1200/GO.20.00269

    Article  Google Scholar 

  32. Gulia S, Kannan S, Ghosh J, Rath S, Maheshwari A, Gupta S (2022) Maintenance therapy with a poly(ADP-ribose) polymerase inhibitor in patients with newly diagnosed advanced epithelial ovarian cancer: individual patient data and trial-level meta-analysis. ESMO Open 7(5):100558. https://doi.org/10.1016/j.esmoop.2022.100558. Epub 2022 Aug 22. PMID: 36007449; PMCID: PMC9588903

  33. Dhillon PK, Yeole BB, Dikshit R, Kurkure AP, Bray F (2011) Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976–2005: an age–period–cohort analysis. Br J Cancer 105(5):723–30. https://doi.org/10.1038/bjc.2011.301

    Article  CAS  Google Scholar 

  34. Indian society of peritoneal surface malignancies (2017) Available at: https://ispsm.org. Accessed 20 Sept 2022

  35. Somashekhar SP, Deo SVS, Sekhon R, Rao Thammineedi S et al (2022) Cytoreductive surgery plus HIPEC for advanced epithelial ovarian cancer: analysis from a multicentric national Indian HIPEC registry of 1,470 patients—an ISPSM collaborative study. J Clin Oncol 40(16):5525–5525

    Article  Google Scholar 

  36. Clinical trials registry-India (2007) ICMR, National institute of medical statistics. Available at: http://ctri.nic.in/Clinicaltrials/advsearch.php. Accessed 7 Aug 2022

  37. Arnold M, Rutherford MJ, Bardot A et al (2019) Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol 20(11):1493–1505. https://doi.org/10.1016/S1470-2045(19)30456-5

    Article  Google Scholar 

  38. NCI Term Browser (2022) National Cancer Institute. NCIthesaurus, Version 22.09ed. Available at: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C17830. Accessed 26 Sept 2022

  39. De Petrillo AD, Fung-Kee-Fung M, Allen H (2019) The evolution of the subspecialty of gynaecologic oncology in Canada and the GOC. J Obstet Gynaecol Can 41(Suppl 2):S231–S233. https://doi.org/10.1016/j.jogc.2019.09.005. PMID: 31785663

  40. Association of Gynaecologic Oncologist of India. Available at: http://www.agoi.org. Accessed 7 Aug 2022

  41. All India Super Speciality Courses, Allotment Process, Counselling. Directorate General of Health Services, Ministry of Health & Family Welfare Government of India, Medical Counseling Committee (MCC). Available at: https://intramcc.nic.in/mccss/seatmatrix.aspx. Accessed 7 Aug 2022

Download references

Author information

Authors and Affiliations

  1. Department of Gynaecological Oncology, Tata Memorial Centre, Homi Baba National Institute, Mumbai, 400012, India

    Rohini Kulkarni

  2. Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, 400012, Maharashtra, India

    Sudeep Gupta

Authors
  1. Rohini Kulkarni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sudeep Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sudeep Gupta.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kulkarni, R., Gupta, S. Gynaecological Oncology in India: Past, Present and Future. Indian J Surg Oncol 13 (Suppl 1), 76–80 (2022). https://doi.org/10.1007/s13193-022-01668-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-022-01668-7

Keywords

Search

Navigation